TG Therapeutics | TGTX - Umsatzkosten





Umsatzkosten Veränderung Datum
AbbVie USD 4.29B 73M 2026-06
Alaunos Therapeutics USD 0 18K 2024-09
Amgen USD 1.87B 271M 2026-06
Ardelyx USD 4.81M 6.04M 2026-03
Bayer EUR 4.54B 692M 2026-06
Biogen USD 945.1M 147.6M 2026-06
Corcept Therapeutics USD 4.06M 1.18M 2026-06
Curis USD 314K 9.96M 2025-12
Gilead Sciences USD 1000M 445M 2026-06
J&J USD 8B 67M 2026-06
Karyopharm Therapeutics USD 1.34M 139K 2026-03
Novartis USD 3.71B 251M 2026-06
Novavax USD 22.1M 608K 2025-12
PTC Therapeutics USD 39.61M 23.31M 2026-03
Puma Biotechnology USD 29.1M 18.44M 2024-09
Regeneron Pharmaceuticals USD 576.5M 92.9M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
TG Therapeutics USD 41.19M 7.68M 2026-06
Verastem USD 3.05M 159K 2026-03
Vertex Pharmaceuticals USD 489.2M 96.4M 2026-06